Syapse IPO

syapse.com

Syapse is the developer of a platform that works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients.

Founded2008
Total Funding to Date$201.76MM
Register for Details

For more details on financing and valuation for Syapse, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Syapse Ticker Symbol

Syapse does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Syapse Stock Price

The stock price for Syapse will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Syapse Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/2/2021 Series G-1 and G-2 $192.94MM $XXX.XX $XXX.XX
5/28/2020 Series F $112.62MM $XXX.XX $XXX.XX
4/23/2019 Series E $239.81MM $XXX.XX $XXX.XX
11/14/2017 Series D $130.43MM $XXX.XX $XXX.XX
1/12/2016 Series C $88.26MM $XXX.XX $XXX.XX
7/10/2014 Series B $30.83MM $XXX.XX $XXX.XX
1/1/2013 Series A $8.43MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Syapse in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B